Waters Corp (WAT)
Price trend score is near the top of its range — score for how it compares with the broader market is on the high side.
WAT scores higher than 88% of the 1,101 tickers we compare it with (Health Care).
As of 9 October 2026, Waters Corp (WAT) scores 62 out of 100 on the Market Census six-factor composite, which puts it at the Above average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 1.57× 30-day average
- 52-week range
- 282.77 – 454.54
- Market cap
- $37.34B
- Earnings date
- 3 Nov 2026
- Volume
- 1,119,546
- Avg. volume (30d)
- 714,644
- Open
- 429.20
- Previous close
- 429.13
- Day's range (regular session)
- 428.19 – 437.53
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- 1.16
- P/E (TTM)
- 250.67
- EPS (TTM)
- 4.00
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
Premium data held for WAT
- 4 SEC Form 4 insider transactions in the last 90 daysPremium
Counts of rows Market Census holds for WAT. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans
What the score says about WAT right now
Waters Corp (WAT) currently scores 62/100 on the Market Census six-factor composite, at the Above average score level. WAT is +1.08% on the day and +1.97% over five sessions as of the most recent tick. Above average sits a bit above the middle. The data for WAT leans good, with some weak spots. WAT's strongest factor is price trend at 87/100 — a very strong read on which way the price has been going. The weakest factor is insider trades at 30/100 — a below average read on insider buying and selling. Insider filings for WAT lean toward selling; on a thinly filed name a few filings can set this reading.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See WAT in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent WAT news
Latest headlines that name Waters, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- Here's Why You Should Retain WAT Stock in Your Portfolio for NowZacks Investment Research
- CellCarta, Waters Corporation collaborate on companion diagnosticsYahoo
- CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics DevelopmentYahoo
- Waters Corporation Schedules Third Quarter 2026 Earnings Conference CallYahoo
- If You Invested $1000 In Waters Stock 20 Years Ago, You Would Have This Much TodayBenzinga
We hide 5 more that told readers to buy or sell, or gave a price target.
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers whose composite scores are closest to WAT’s 62, all within 1 point.
Sorted by closeness to WAT’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.